TrialBreast cancer research and treatment2014

C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients.

Erik Hilborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.